Company: GE
Filing Date: 2025-10-21
Form Type: 10-Q
Source: 0000040545-25-000132
Chunk: 79

Company: GENERAL ELECTRIC CO
Filing Date: 2025-10-21
Form: 10-Q
Item: Item 4
Chunk 79
---
Total average equivalent shares1,065 1,058 1,093 1,083 EPS from continuing operations$2.04 $2.06 $1.56 $1.57 EPS from discontinued operations(0.02)(0.02)0.13 0.14 Net EPS2.02 2.04 1.70 1.71 Potentially dilutive securities(b)1 3 Nine months ended September 3020252024(Earnings for per-share calculation, shares in millions, per-share amounts in dollars)DilutedBasicDilutedBasicNet income (loss) from continuing operations attributable to common shareholders(a)6,143 6,149 4,766 4,766 Net income (loss) from discontinued operations 14 14 (108)(108)Net income (loss) attributable to common shareholders(a)6,157 6,163 4,657 4,657 Shares of common stock outstanding1,064 1,064 1,087 1,087 Employee compensation-related shares (including stock options)8 — 11 — Total average equivalent shares1,071 1,064 1,098 1,087 EPS from continuing operations$5.73 $5.78 $4.34 $4.38 EPS from discontinued operations0.01 0.01 (0.10)(0.10)Net EPS5.75 5.79 4.24 4.28 Potentially dilutive securities(b)2 7 (a) Included in 2025 is a dilutive adjustment for the change in income for forward purchase contracts that may be settled in stock.(b) Outstanding stock awards not included in the computation of diluted earnings per share because their effect was antidilutive.Our unvested restricted stock unit awards that contain non-forfeitable rights to dividends or dividend equivalents are considered participating securities and historically have been included in the calculation pursuant to the two-class method. For the three and nine months ended September 30, 2025, and the comparative period in 2024, and the Company calculates earnings per share using the treasury stock method.

NOTE 18. OTHER INCOME (LOSS)

Three months ended September 30Nine months ended September 302025202420252024Investment in GE HealthCare realized and unrealized gain (loss)$— $336 $— $555